# Breakthrough Oral Drug Shows Promise for Alzheimer’s

Newsy: Alzheimer’s News Weekly
Published: 2026-04-27T13:30:00.204Z
Source: https://newsyai.com/edition/2c30cc22-016e-4a3f-b466-276fecb68969
Archive: https://newsyai.com/newsy/2e52bc28-656d-42e4-981f-28a7be9142df.md

---

# Alzheimer’s Treatment Briefing: Oral Drug Delivers Multi-Target Wins in New Trial

**Coverage period: April 21–April 27, 2026**

Below are this week’s most meaningful, truly **new** developments, ranked by impact on treatment and access.[[1]](https://www.nature.com/articles/s44400-026-00073-z)[[2]](https://www.alzforum.org/news/conference-coverage/microglia-behind-wheel-cars-bust-av-plaques)[[3]](https://www.alz.org/news/2026/hhs-secretary-kennedy-calls-for-early-alzheimers-screening)

**1. Oral pill buntanetap slows memory loss in early Alzheimer’s patients with right biology**  
- **Overview**  
Annovis Bio released results from a large Phase 2/3 trial testing buntanetap (also called Posiphen), a daily pill for people with mild to moderate Alzheimer’s. Among 351 participants, those confirmed to have the disease’s key brain signs (via biomarkers) saw clear memory gains on tests—the higher the dose (up to 30 mg), the better the score, like gaining back steps on a slippery slope. It cut harmful brain proteins, inflammation, and nerve damage markers. Side effects were mild, similar to fake pills, with no serious issues.[[1]](https://www.nature.com/articles/s44400-026-00073-z)  
- **Why this matters**  
Unlike single-shot plaque removers, this pill attacks multiple brain toxins at once—like a janitor team clearing trash, tangles, and spills simultaneously—offering a simpler, needle-free option for early cases. Positive signals push it toward full approval in ongoing bigger trials, potentially expanding easy home treatments.

**2. Lab-made brain cleanup cells supercharge plaque removal in animal tests**  
- **Overview**  
At the AD/PD 2026 conference, two teams showed "CAR-microglia"—brain immune cells tweaked with special sensors (inspired by cancer therapies)—devouring sticky plaques twice as fast as normal cells. In mouse brains and human-like tissue models, they cleared up to 95% of plaques over months, homing in precisely without harming healthy parts, and stayed active long-term after one transplant.[[2]](https://www.alzforum.org/news/conference-coverage/microglia-behind-wheel-cars-bust-av-plaques)  
- **Why this matters**  
The brain’s natural cleanup crew often slacks in Alzheimer’s; these upgraded cells act like super-vacuums that migrate everywhere and persist, possibly delivering lasting relief with fewer side effects than current infusions—hinting at a "set it and forget it" fix if human tests pan out.

**3. Top health official pushes for routine blood tests to catch Alzheimer’s early**  
- **Overview**  
On April 21, HHS Secretary Robert F. Kennedy Jr. urged Medicare to cover simple finger-prick blood tests for Alzheimer’s signs in at-risk people, calling delays "regulatory malpractice." He highlighted how early detection lets treatments—like plaque-clearers—work best before symptoms worsen, with bills like the ASAP Act aiming to make this standard, like cancer screenings.[[3]](https://www.alz.org/news/2026/hhs-secretary-kennedy-calls-for-early-alzheimers-screening)  
- **Why this matters**  
Most early cases go undiagnosed, missing the treatment window—like fixing a roof leak before the house floods. Government backing could unlock therapies for millions sooner, boosting real-world success and planning time.

**4. Sound waves tuned to brain rhythm boost memory and cut damage in mice**  
- **Overview**  
A new study tested transcranial ultrasound—gentle sound waves pulsed at 40 Hz (matching healthy brain waves)—on Alzheimer’s mice for two weeks. It improved maze navigation and memory, shrank plaques, dialed down brain swelling, and strengthened nerve connections without drugs or surgery.[[4]](https://pmc.ncbi.nlm.nih.gov/articles/PMC13093894)  
- **Why this matters**  
Like syncing a band to keep rhythm, this non-invasive zap could rally the brain’s harmony externally, offering a safe add-on or starter therapy—especially exciting for hard-to-treat inflammation, with human potential ahead.

## What this means for care right now
- **Multi-target pills rising**: Buntanetap’s data spotlights oral options; discuss trials if mild symptoms fit.[[1]](https://www.nature.com/articles/s44400-026-00073-z)  
- **Cell upgrades on horizon**: CAR-microglia previews safer plaque busters; watch for safety trials.[[2]](https://www.alzforum.org/news/conference-coverage/microglia-behind-wheel-cars-bust-av-plaques)  
- **Screen early**: Advocate for blood tests via policy pushes—key to timely drugs.[[3]](https://www.alz.org/news/2026/hhs-secretary-kennedy-calls-for-early-alzheimers-screening)  
- **Non-drug tools**: Ultrasound hints at home-like aids; pair with lifestyle for best defense.[[4]](https://pmc.ncbi.nlm.nih.gov/articles/PMC13093894)

## Sources
- Buntanetap Phase 2/3: [Nature npj Dementia](https://www.nature.com/articles/s44400-026-00073-z)[[1]](https://www.nature.com/articles/s44400-026-00073-z)  
- CAR-microglia: [Alzforum AD/PD Coverage](https://www.alzforum.org/news/conference-coverage/microglia-behind-wheel-cars-bust-av-plaques)[[2]](https://www.alzforum.org/news/conference-coverage/microglia-behind-wheel-cars-bust-av-plaques)  
- HHS Screening Call: [Alz.org](https://www.alz.org/news/2026/hhs-secretary-kennedy-calls-for-early-alzheimers-screening)[[3]](https://www.alz.org/news/2026/hhs-secretary-kennedy-calls-for-early-alzheimers-screening)  
- Ultrasound Study: [PMC](https://pmc.ncbi.nlm.nih.gov/articles/PMC13093894)[[4]](https://pmc.ncbi.nlm.nih.gov/articles/PMC13093894)  

Fresh preclinical sparks and human data signal diverse treatment paths ahead.
